CAS: 30914-89-7 - 2-[3-(Trifluoromethyl)phenyl]morpholine
Formel:C11H12F3NO
InChl:InChI=1S/C11H12F3NO/c12-11(13,14)9-3-1-2-8(6-9)10-7-15-4-5-16-10/h1-3,6,10,15H,4-5,7H2
InChI Key:InChIKey=GXPYCYWPUGKQIJ-UHFFFAOYSA-N
SMILES:FC(F)(F)C=1C=CC=C(C1)C2OCCNC2
- Synonyme:
- 1,4-Oxazine, tetrahydro-2-(alpha,alpha,alpha-trifluoro-m-tolyl)-
- 1841 Cerm
- 1841Cerm
- 2-(3-(Trifluoromethyl)phenyl)morpholine
- 2-(3-Trifluoromethylphenyl)morpholine
- 2-(alpha,alpha,alpha-Trifluoro-m-tolyl)morpholine
- Brn 1215543
- Cerm-1841
- Flumexadol [INN]
- Flumexadolum
- Mehr Synonyme anzeigen
- Flumexadolum [INN-Latin]
- Morpholine, 2-[3-(trifluoromethyl)phenyl]-
- Tetrahydro-2-(alpha,alpha,alpha-trifluoro-m-tolyl)-1,4-oxazine
- Unii-V9783Uel0F
- Flumexadol
Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
---|---|---|---|---|
2-(3-(TRIFLUOROMETHYL)PHENYL)MORPHOLINE REF: 10-F468582CAS: 30914-89-7 | 97.0% | Nachfragen | Fr 10 Jan 25 | |
2-[3-(Trifluoromethyl)phenyl]morpholine REF: 3D-FBA91489CAS: 30914-89-7 | Min. 95% | Nachfragen | Di 11 Feb 25 | |
Flumexadol REF: TM-T11302CAS: 30914-89-7 | 98% | Nachfragen | Di 18 Feb 25 |
2-(3-(TRIFLUOROMETHYL)PHENYL)MORPHOLINE
CAS:30914-89-7
Reinheit:
97.0%
Molekulargewicht:
231.21800231933594
Ref: 10-F468582
250mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 10. Januar 2025
2-[3-(Trifluoromethyl)phenyl]morpholine
CAS:30914-89-7
2-[3-(Trifluoromethyl)phenyl]morpholine (TFM) is a hydrophobic, insoluble compound that can be reconstituted in water at a …
Formel:
C11H12F3NO
Reinheit:
Min. 95%
Molekulargewicht:
231.21 g/mol
Ref: 3D-FBA91489
1g | 961,00 € | ||
100mg | 242,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 11. Februar 2025
Flumexadol
CAS:30914-89-7
Flumexadol is a selective 5-HT2C receptor agonist with an affinity (Ki) of 25 nM for …
Formel:
C11H12F3NO
Reinheit:
98%
Farbe und Form:
Solid
Molekulargewicht:
231.21
Ref: TM-T11302
50mg | Nachfragen | ||
100mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 18. Februar 2025